Cigna Investments Inc. New Purchases Shares of 1,310 Credicorp Ltd. (NYSE:BAP)
by Teresa Graham · The Cerbat GemCigna Investments Inc. New purchased a new stake in Credicorp Ltd. (NYSE:BAP – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,310 shares of the bank’s stock, valued at approximately $237,000.
A number of other institutional investors have also recently made changes to their positions in the stock. Massachusetts Financial Services Co. MA grew its position in shares of Credicorp by 0.9% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,029,014 shares of the bank’s stock valued at $488,671,000 after buying an additional 25,972 shares during the last quarter. Baillie Gifford & Co. grew its position in shares of Credicorp by 22.0% in the 2nd quarter. Baillie Gifford & Co. now owns 1,632,852 shares of the bank’s stock valued at $263,428,000 after buying an additional 294,596 shares during the last quarter. Pzena Investment Management LLC grew its position in shares of Credicorp by 3.9% in the 1st quarter. Pzena Investment Management LLC now owns 933,764 shares of the bank’s stock valued at $158,208,000 after buying an additional 35,167 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Credicorp by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 753,205 shares of the bank’s stock valued at $127,616,000 after buying an additional 10,527 shares during the last quarter. Finally, Driehaus Capital Management LLC lifted its stake in shares of Credicorp by 78.8% in the 2nd quarter. Driehaus Capital Management LLC now owns 358,784 shares of the bank’s stock valued at $57,883,000 after purchasing an additional 158,175 shares during the period. Institutional investors own 89.81% of the company’s stock.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group boosted their price objective on Credicorp from $143.00 to $160.00 and gave the company a “sell” rating in a research note on Tuesday, October 8th.
Credicorp Stock Performance
Shares of Credicorp stock opened at $181.76 on Friday. The company has a market cap of $14.46 billion, a PE ratio of 10.96, a price-to-earnings-growth ratio of 0.64 and a beta of 1.14. Credicorp Ltd. has a 52 week low of $116.42 and a 52 week high of $193.25. The business has a 50 day moving average price of $180.32 and a 200-day moving average price of $170.83. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.54.
Credicorp (NYSE:BAP – Get Free Report) last released its earnings results on Thursday, August 8th. The bank reported $4.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.64 by ($0.15). The business had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.32 billion. Credicorp had a net margin of 19.31% and a return on equity of 14.86%. Equities analysts anticipate that Credicorp Ltd. will post 18.81 earnings per share for the current fiscal year.
Credicorp Cuts Dividend
The company also recently disclosed an annual dividend, which was paid on Friday, October 18th. Shareholders of record on Monday, September 23rd were issued a dividend of $2.9084 per share. This represents a yield of 3.8%. The ex-dividend date of this dividend was Monday, September 23rd. Credicorp’s dividend payout ratio (DPR) is 55.97%.
About Credicorp
Credicorp Ltd. provides various financial, insurance, and health services and products primarily in Peru and internationally. It operates through Universal Banking, Insurance and Pensions, Microfinance, and Investment Banking and Equity Management segments. The Universal Banking segment grants various credits and financial instruments to individuals and legal entities; and various deposits and current accounts.
Further Reading
- Five stocks we like better than Credicorp
- Top Biotech Stocks: Exploring Innovation Opportunities
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is MarketRank™? How to Use it
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- What Are Dividend Achievers? An Introduction
- Top Nuclear Stocks Thriving on Soaring Energy Demand